Sterodimas Aris, Nicaretta Beatriz, Koytsouveli Agathi, Moutafis Argyris, Champsas Grigoris
Metropolitan General Hospital, 264 Mesogeion Ave, 15562, Athens, Greece.
Vice Head Plastic & Reconstructive Surgery Department, Metropolitan General Hospital, Athens, Greece.
Aesthetic Plast Surg. 2025 Mar 21. doi: 10.1007/s00266-025-04737-8.
Helium plasma radio frequency (RF) has emerged as a minimally invasive option for treating facial laxity. This study aims to evaluate its efficacy and safety for addressing forehead and brow laxity and ptosis.
In this retrospective, single-center study, medical records for 30 consecutive patients treated with helium plasma RF in the forehead and brow from March 2018 to September 2022 were reviewed. Inclusion criteria were age ≥18 years and having undergone treated in the forehead with helium plasma RF. Patients with prior or concurrent brow/forehead interventions were excluded. Primary endpoints were photographic assessments by blinded review and patient satisfaction measured via questionnaire.
Of the 30 patients, seven patients consented to photographic review, and all 30 participated in the patient satisfaction questionnaire. Blinded reviewers correctly identified posttreatment images in 71.4% (5/7) of cases. Patient satisfaction was high, with 100% (30/30) reporting visible improvements and willingness to recommend the procedure. Notable improvements included reduced forehead lines (56.7%), elevated eyebrows (46.7%), and a more youthful appearance (46.7%). Adverse effects were minor and expected, with bruising recorded in 20% (6/30) of patients and edema/swelling in 16.7% (5/30) of patients, all resolving within 10 days, without intervention.
Helium plasma RF demonstrates significant potential as a minimally invasive treatment for brow and forehead laxity, with high patient satisfaction and a favorable safety profile. These preliminary findings warrant further prospective studies with larger sample sizes to confirm efficacy and long-term benefits. Helium plasma RF may provide a valuable alternative to traditional aesthetic procedures for the forehead and brow.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
氦等离子体射频（RF）已成为治疗面部松弛的一种微创选择。本研究旨在评估其治疗前额和眉部松弛及上睑下垂的疗效和安全性。
在这项回顾性单中心研究中，回顾了2018年3月至2022年9月连续30例接受前额和眉部氦等离子体射频治疗患者的病历。纳入标准为年龄≥18岁且在前额接受过氦等离子体射频治疗。排除先前或同时进行过眉部/前额干预的患者。主要终点是通过盲法评估进行的照片评估以及通过问卷调查测量的患者满意度。
30例患者中，7例患者同意进行照片评估，所有30例患者均参与了患者满意度问卷调查。盲法评估者在71.4%（5/7）的病例中正确识别出治疗后的图像。患者满意度较高，100%（30/30）报告有明显改善并愿意推荐该手术。显著改善包括前额皱纹减少（56.7%）、眉毛提升（46.7%）和外观更显年轻（46.7%）。不良反应轻微且为预期情况，20%（6/30）的患者出现瘀斑，16.7%（5/30）的患者出现水肿/肿胀，所有这些均在10天内自行消退，无需干预。
氦等离子体射频作为一种治疗眉部和前额松弛的微创治疗方法显示出巨大潜力，患者满意度高且安全性良好。这些初步发现需要进一步开展更大样本量的前瞻性研究以证实其疗效和长期益处。氦等离子体射频可能为前额和眉部的传统美容手术提供一种有价值的替代方法。
证据级别IV：本期刊要求作者为每篇文章指定证据级别。有关这些循证医学评级的完整描述，请参阅目录或在线作者指南 www.springer.com/00266 。
